Trials / Recruiting
RecruitingNCT07026240
Post-operative Monitoring of Gastric Cancer
Post-operative Monitoring of Gastric Cancer Using Circulating DNA in Blood Samples
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 258 (estimated)
- Sponsor
- Suzhou Huhu Health & Technology Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to determine the performance of non-invasive new multi-target biomarkers in the post-operative monitoring of gastric cancer.
Detailed description
This study aims to develop and validate a new non-invasive detection method for postoperative monitoring of gastric cancer in the blood. Blood will also be collected at various time points post-operatively. We will determine whether these new biomarkers can be used as prognostic biomarkers to predict tumor recurrence and metastasis. We will also determine whether these new biomarkers detect tumor recurrence and metastasis earlier than methods currently used in the clinic such as imaging and tumor biomarkers CA19-9, CEA, and CA72-4. This study is a prospective and multi-center study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | DNA test | a new non-invasive detection method for postoperative monitoring of gastric cancer in the blood |
Timeline
- Start date
- 2024-02-18
- Primary completion
- 2026-01-07
- Completion
- 2026-01-07
- First posted
- 2025-06-18
- Last updated
- 2025-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07026240. Inclusion in this directory is not an endorsement.